LeClair Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Buy
+9,922
New +$570K 0.3% 62
2026
Q1
Sell
-9,636
Closed -$520K 112
2025
Q4
$520K Hold
9,636
0.3% 54
2025
Q3
$435K Sell
9,636
-40
-0.4% -$1.87K 0.27% 53
2025
Q2
$448K Sell
9,676
-13
-0.1% -$638 0.3% 56
2025
Q1
$591K Buy
9,689
+26
+0.3% +$1.52K 0.43% 49
2024
Q4
$547K Buy
+9,663
New +$540K 0.36% 53

Other funds holding BMY

LeClair Wealth Partners's BMY Position: Q2 2026 in Review

LeClair Wealth Partners opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 9,922 shares worth $572K. The stake represents 0.3% of the portfolio and ranks #62 among its holdings. This is a return to the name: LeClair Wealth Partners previously reported a position in BMY as recently as Q4 2025.

LeClair Wealth Partners first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $591K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • LeClair Wealth Partners held 9,922 shares of Bristol-Myers Squibb worth $572K as of Q2 2026.
  • Bristol-Myers Squibb was a new LeClair Wealth Partners position in Q2 2026.
  • Bristol-Myers Squibb made up 0.3% of LeClair Wealth Partners's portfolio in Q2 2026, its #62 holding.
  • LeClair Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • LeClair Wealth Partners's Bristol-Myers Squibb position peaked at $591K in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on LeClair Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.